Pharma Journalist -

Jazz Pharmaceuticals plc announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Modeyso (dordaviprone) for the treatment of adult and pediatric…
Read More...

The 3rd Spatial Biology for Drug Development Summit Boston, MA | October 22-23, 2025 *Free to Attend for Biopharma Experts Spatial biology is at a turning point. Advances in…
Read More...

Astria Therapeutics, Inc. has entered into an exclusive licensing agreement with Kaken Pharmaceutical Co., Ltd., granting Kaken the rights to develop and commercialize navenibart in…
Read More...

Axplora, a global leader in API small molecule manufacturing, has announced a €6.5 million investment to expand production capacity at its Vizag site in India. This move aims to boost…
Read More...

SERB Pharmaceuticals, a global specialty pharma company focused on rare diseases and medical emergencies, announced it has entered a definitive agreement to acquire Y-mAbs Therapeutics,…
Read More...

Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental biologics license application (sBLA) for Breyanzi (lisocabtagene…
Read More...

Agios Pharmaceuticals, Inc. announced that the Saudi Food and Drug Authority (SFDA) has approved PYRUKYND (mitapivat) for the treatment of adult patients with non-transfusion-dependent…
Read More...

Atombeat Inc., a leader in AI-driven drug discovery, and BioDuro, a global contract research, development, and manufacturing organization (CRDMO), have announced a strategic partnership…
Read More...

Sandoz has signed a non-binding term sheet with Evotec SE to potentially acquire Just–Evotec Biologics EU SAS, including its state-of-the-art J.POD biologics development and…
Read More...

Repligen Corporation has announced a strategic partnership with Novasign aimed at accelerating the digital transformation of bioprocessing. The collaboration will focus on integrating…
Read More...